Elisabeth Calderón

PhD in Immunology

[Isabelle Meyts @IsabelleMeyts]

The long-awaited 2024 update and phenotypic classification are here:

[Isabelle Meyts @IsabelleMeyts]

The IUIS Inborn Errors Update is online!

[Esteban Ballestar @eballestar]

Do not miss this #postdoctoral opportunity in our team!

[Silvia Sánchez-Ramón @SilviaSchzRamon]

Excited to share our latest findings on the complex challenges of diagnosing PID in the context of SID linked to B-cell malignancies. Stay tuned for insights!

https://t.co/Y6I8HaoANq

[Silvia Sánchez-Ramón @SilviaSchzRamon]

Dissecting the crossovers between SID to B hematological malignancy & IEI at @ESIDsociety
San Carlos Immunology team
#somosclinico

[Elisabeth Calderón @calder_eli]

Fantastic talks by Dr. Jacques Rivière and Dr. Eleonora Gambineri about how truncate time to immunodeficiency diagnosis at #ESID2024 #Grifols symposium today

[Eric Topol @EricTopol]

Engineered T cells (CAR T) is a transformative Rx for cancer and emerging for autoimmune diseases.
A meta-analysis of >7,600 patients in 18 clinical trials and 28 real-world studies highlights the risk of infection during follow-up as the principal cause of non-relapse mortality
https://t.co/7skI72wtY3
@NatureMedicine @KRejeski @DavidCdSMD @MSKCancerCenter

[IPOPI @ipopi_info]

🌍 Our first day at the Global Stakeholders Summit is actively unfolding with vibrant discussions, exploring new horizons and innovations for global progress in PIDs!

#GlobalStakeholdersSummit #PIDs #Innovation

[Silvia Sánchez-Ramón @SilviaSchzRamon]

Economic Impact of Immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer. A single center observational study

https://t.co/i7SAaU88fQ

[Esteban Ballestar @eballestar]

Do not miss it!!! #PrimaryImmunodeficiencies @hospitaldelmar

[Don Vinh @DonaldVinh]

The legendary Dr. Cunningham-Rundles sharing her pearls of wisdom about IG replacement therapy ⁦@ClinImmSoc⁩

[Elisabeth Calderón @calder_eli]

Opening the CIS meeting 2024 with a Tribute to Vicki Modell by Dr. Orange @ClinImmSoc @jordanorange #CIS2024 #PIDD

[Eric Topol @EricTopol]

Patients with immunodeficiency are often undiagnosed or experience marked delay in detection.
#AI to the rescue.
https://t.co/OVkDQGz1Id @ScienceTM @ManishButte @UCLA

[Elisabeth Calderón @calder_eli]

Congratulations Dr. Cunningham-Rundles on this Award!

[PPTAEurope @PPTAEurope]

Congratulations to Dr. Charlotte Cunningham-Rundles, recipient of the 2024 Joachim Hilfenhaus Award. She receives this honor for her exceptional contributions to the field of immunology. Learn more about her impressive work at @IcahnMountSinai: https://t.co/C4eET0f60Z #IPPC2024

[Silvia Sánchez-Ramón @SilviaSchzRamon]

Exploring Gastric Cancer Genetics: A Turning Point in Common Variable Immunodeficiency - ScienceDirect https://t.co/rbP0LBFN3y

[Elisabeth Calderón @calder_eli]

It was a pleasure to meet the three ASPIRE award winners Dr. Laia Alsina (2021), Dr. Emily Edwards (2022) and Dr. Adrian Shields (2023) at #IPIC2023 #IPICmoment @laiaalsina_ @emmye1984 @immunologydoc

[Elisabeth Calderón @calder_eli]

@NRider70 Thanks to you!

[Elisabeth Calderón @calder_eli]

How can artificial intellingence help detect patients at risk of primary immunodeficiency? Dr. Nick Rider @NRider70 explained it to us at #IPIC2023 #IPICmoment . Excellent talk!

[Elisabeth Calderón @calder_eli]

Fantastic talk by Dr. Pere Soler-Palacín about new tools for PID diagnosis #PID #IPIC2023 #IPICmoment ⁦@bcnpidfound⁩ ⁦@Immuno_HUVH⁩